Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY

v3.20.1
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)
Common Stock [Member]
Additional Paid-In Capital [Member]
Retained Earnings/ (Accumulated Deficit) [Member]
Total
Balance at Dec. 31, 2018 $ 431 $ 24,569 $ (451) $ 24,549
Balance in (shares) at Dec. 31, 2018 4,312,500      
Sale of 17,250,000 Units, net of underwriting discounts and offering costs $ 1,725 168,484,174 0 168,485,899
Sale of 17,250,000 Units, net of underwriting discounts and offering costs (in shares) 17,250,000      
Sale of 717,500 Private Units $ 72 7,174,928 0 7,175,000
Sale of 717,500 Private Units (in shares) 717,500      
Common stock subject to possible redemption $ (1,693) (171,039,807)   (171,041,500)
Common stock subject to possible redemption (in shares) (16,934,802)      
Net income $ 0 0 356,058 356,058
Balance at Mar. 31, 2019 $ 535 4,643,864 355,607 5,000,006
Balance in (shares) at Mar. 31, 2019 5,345,198      
Balance at Dec. 31, 2019 $ 529 4,036,415 963,059 5,000,003
Balance in (shares) at Dec. 31, 2019 5,285,054      
Common stock subject to possible redemption $ (3) (215,723) 0 (215,726)
Common stock subject to possible redemption (in shares) (21,359)      
Net income $ 0 0 215,725 215,725
Balance at Mar. 31, 2020 $ 526 $ 3,820,692 $ 1,178,784 $ 5,000,002
Balance in (shares) at Mar. 31, 2020 5,263,695